Table 2.

AT1R antibodies values in glomerular diseases compared to the range 10 U/ml and comparison of them using chi-square test

Glomerular disease	Number of patients	% of patients with AT1R antibodies < 10 U/ml	% of patients with AT1R antibodies > 10 U/ml	Membranous nephropathy	Focal and segmental glomerulosclerosis	Systemic lupus erythematosus	IgA nephropathy	Mesangial proliferative non-IgA glomerulonephritis	C-ANCA vasculitis	P-ANCA vasculitis
Membranous nephropathy	18	100	0	NA	p ≤ 0.05	p ≤ 0.001	p ≤ 0.001	NS	p ≤ 0.001	p ≤ 0.001
Focal and segmental glomerulosclerosis	25	96	4	p ≤ 0.05	NA	p ≤ 0.001	p ≤ 0.05	p ≤ 0.05	p ≤ 0.001	p ≤ 0.001
Systemic lupus erythematosus	17	59	41	p ≤ 0.001	p ≤ 0.001	NA	p ≤ 0.001	p ≤ 0.001	NS	p ≤ 0.001
IgA nephropathy	14	86	14	p ≤ 0.001	p ≤ 0.05	p ≤ 0.001	NA	p ≤ 0.001	p ≤ 0.01	NS
Mesangial proliferative non-IgA glomerulonephritis	6	100	0	NS	p ≤ 0.05	p ≤ 0.001	p ≤ 0.001	NA	p ≤ 0.001	p ≤ 0.001
C-ANCA vasculitis	40	70	30	p ≤ 0.001	p ≤ 0.001	NS	p ≤ 0.01	p ≤ 0.001	NA	NS
P-ANCA vasculitis	16	81	19	p ≤ 0.001	p ≤ 0.001	p ≤ 0.001	NS	p ≤ 0.001	NS	NA